1. Home
  2. CERS vs FPH Comparison

CERS vs FPH Comparison

Compare CERS & FPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERS
  • FPH
  • Stock Information
  • Founded
  • CERS 1991
  • FPH 2009
  • Country
  • CERS United States
  • FPH United States
  • Employees
  • CERS N/A
  • FPH N/A
  • Industry
  • CERS EDP Services
  • FPH Real Estate
  • Sector
  • CERS Technology
  • FPH Finance
  • Exchange
  • CERS Nasdaq
  • FPH Nasdaq
  • Market Cap
  • CERS 324.3M
  • FPH 267.1M
  • IPO Year
  • CERS 1997
  • FPH 2017
  • Fundamental
  • Price
  • CERS $1.58
  • FPH $3.55
  • Analyst Decision
  • CERS Buy
  • FPH
  • Analyst Count
  • CERS 3
  • FPH 0
  • Target Price
  • CERS $3.17
  • FPH N/A
  • AVG Volume (30 Days)
  • CERS 1.2M
  • FPH 195.3K
  • Earning Date
  • CERS 10-30-2024
  • FPH 01-16-2025
  • Dividend Yield
  • CERS N/A
  • FPH N/A
  • EPS Growth
  • CERS N/A
  • FPH 35.57
  • EPS
  • CERS N/A
  • FPH 0.70
  • Revenue
  • CERS $176,229,000.00
  • FPH $196,899,000.00
  • Revenue This Year
  • CERS $26.47
  • FPH N/A
  • Revenue Next Year
  • CERS $11.48
  • FPH N/A
  • P/E Ratio
  • CERS N/A
  • FPH $5.10
  • Revenue Growth
  • CERS 14.71
  • FPH 79.04
  • 52 Week Low
  • CERS $1.38
  • FPH $2.60
  • 52 Week High
  • CERS $2.59
  • FPH $4.39
  • Technical
  • Relative Strength Index (RSI)
  • CERS 38.88
  • FPH 34.56
  • Support Level
  • CERS $1.53
  • FPH $3.42
  • Resistance Level
  • CERS $1.83
  • FPH $3.85
  • Average True Range (ATR)
  • CERS 0.11
  • FPH 0.13
  • MACD
  • CERS -0.03
  • FPH -0.05
  • Stochastic Oscillator
  • CERS 13.89
  • FPH 18.18

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

About FPH Five Point Holdings LLC

Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational and recreational elements, as well as civic areas, parks, and open spaces. Its four reportable segments are Valencia, San Francisco, Great Park, and Commercial. It derives the majority of revenue from the Great Park segment which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.

Share on Social Networks: